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Summary 
The in-vitro activity ofmiconazole against Candida albicans (NCPF 3262) was investigated using Time-
survival curves. An HPLC assay was also developed to produce a pH-solubility profile which showed 
that miconazole solubility varied from (2.5 ±0.3) mg/L at pH 12 to (28.9 ± 0.6) mg/L at pH 5. Time survival 
curve determinations demonstrated a relationship between miconazole concentration and the area 
under the curve (AUC). In controlled conditions using buffered aqueous solutions of miconazole 
(8 mg/L), a change in pH from 8 to 5 resulted in an increase in the antifungal activity of miconazole. 
Experiments performed in buffered YNB using the same concentration of miconazole showed that a 
change in pH from 7 to 5 resulted in a decrease in miconazole antifungal activity. Such results indicate 
that apart from the well known inhibitory effects that the growth media have on azole activity, pH at 
which tests were performed may also influence growth of C. albicans in batch culture. 
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Introduction 
Time-survival curves have recently been used to 
evaluate the effect of variation of the test 
conditions on antimicrobial susceptibility of 
microorganisms to antimicrobial agents. 
Interpretation of this kind of data entails the 
comparison of the pattern of survival, rates of 
kill or reduced growth and viable count at 24h1,2. 
Every organism has a range of pH over which 
growth is possible and an optimal pH at which 
growth is most favoured, different 
microorganisms are known to have different 
tolerances to environmental change including pH 
Fungi are reported to be more tolerant to pH 
changes than bacteria3. Miconazole is an azole 
antifungal agent with a pKa of 6.74,that is used in 
the treatment of candidosis5. Reports in literature 
indicate that the unprotonated form of the drug 
is the one that is responsible for antifungal 
activity6. 
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A series of experiments to investigate the 
effect that pH has on in vitro activity against 
Candida albicans in a defined growing 
medium were designed. To complement this 
in vitro microbiological work a simple 
reversed phase High Performance Liquid 
Chromatography (HPLC) assay was 
developed. Reports in the literature suggest 
that the chromatographic techniques 
represent the favourite approach for 
quantitation of azoles such as miconazole7. 
The assay was a simple chromatographic 
separation involving a binary mixture on a 
reversed phase column. From the data 
obtained a pH solubility profile of 
miconazole in aqueous medium constructed. 
The data obtained was used to investigate 
the possibility of a correlation between 
miconazole activity and pH. 
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Method 
Materials required for the HPLC assay: 
The apparatus used throughout the HPLC assay 
for the determination of the solubility ofmiconazole 
in aqueous solution (at pH values that range from 
5 to 8) consisted of: An Ultracentrifuge (MSE® 
Superspeed 50) fitted with a 30° angle set to reach 
an average RCF of 100,000 g and a rotor speed of 
35,000 rpm, a Shimadzu®L.C. 6A chromatograph 
fitted with a rheodyne injector and a 20 ml injection 
loop, a Shimadzu®UV -visible variable wavelength 
detector, a 25 cm x 4.6 mm i.d., 5 1-1m particle size 
reverse phase column (Spherisorb® ODS 2. Phase 
Separations, UK), and a single channel strip chart 
recorder. (Gallencamp®, UK). Reference materials, 
chemicals and solvents used were, miconazole 
(Janssen®, Belgium) .. ketoconazole (Janssen®, 
Belgium), dimethyl formamide (DMF) (Sigma®, 
UK), ammonium phosphate (BDH®, UK) deionised 
water, methanol HPLC grade (Labscan®, UK). The 
mobile phase selected for this assay consisted of a 
95% methanol and 5% O.OSM ammonium 
dihydrogen phosphate mixture. After mixing, the 
mobile phase was filtered through 0.45 !-LID PTFE 
filters to degas and remove any residual particulate 
matter. 
Materials required for the microbiology 
experimentation: 
C. albicans (NCPF 3262), maintained on Bacto Yeast 
Morphology Agar (BYMA, Difco, USA) slopes at 
4 oc., Yeast Nitrogen Base (Bacto®YNB, Difco, USA) 
prepared according to the Wickerham Formula8, 
Sorensen' s Buffer, filtration apparatus (Millipore®, 
USA),0.22!-1mand0.45!-1mfiltersandstocksolutions 
of miconazole (lOOOmg/L)which were allowed to 
self sterilise9. 
Methods used in the HPLC assay: 
Samples used in the HPLC assay were prepared 
from a stock solution of miconazole (1000 mg/L) in 
methanol (100% vI v' HPLC grade). A series of 
standard solutions that ranged from 0.5 to 
10 mg/L were used to construct calibration curves 
of miconazole in Sorensen's buffer (pH 7). The 
solutions were vortexed for 1 min and a 2 ml aliquot 
taken and shaken, on a rotary mixer, for one hour 
with a volume (2 ml) of chloroform. The extraction 
process was repeated a second time with a further 
2 ml volume of chloroform. The chloroform layers 
were removed, dried under a stream of nitrogen at 
a constant temperature of 35°C and reconstituted in 
a total volume of 1 ml of a 2.5 mg/L solution of 
ketoconazole (internal standard) in mobile phase, 
previously filtered through 0.45!-Lm PTFE filter. 
Triplicate injections (20 1-11) were made for each 
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solution, peak heights for miconazole (m) and 
ketoconazole (k) were measured manually and the 
mean peak height ratio (m/k) and standard 
deviation (sd) were calculated for each 
concentration. Samples for analysis consisted of 
saturated solutions of miconazole in a 1% solution 
of methanol in Sorensen' s buffer, prepared at pH 5, 
5.5, 6.0, 7.0 and 8.0 respectively. The saturated 
solutions were left for 24h in a shaking water bath 
set to 25°C and 100 strokes/min. About 20 ml of 
each solution was placed in ultracentrifuge tubes 
that were balanced to the nearest 10 mg. The 
solutions were spun down for 90 min at an average 
RCF of 100,000 g. An aliquot (2 ml) of supernatant 
was taken from each tube and subjected to a similar 
extraction procedure and then finally reconstituted 
in 1 ml of mobile phase containing 2.5 mg/L 
ketoconazole internal standard. This process was 
carried out over forty eight hours, during which a 
total of three sets oft est solutions for each pH value 
were prepared. On each test day, the calibration 
standards and the test solutions were run. Reversed 
phase chromatography using an octadecylsilane 
(ODS) column together with a mobile phase that 
consisted of 95% methanol and 5% O.OSM 
ammonium dihydrogen phosphate was used 
throughout the experiment. The mobile phase was 
pumped through the chromatograph at ambient 
temperature, at a rate of 2 ml/min and the peaks 
detected at a wavelength of 230 nm with 0.02 
attenuation value. Traces obtained from the 
manually injected samples (Figure 1) were recorded 
on a strip chart recorder set at a chart speed of 
5 mm/ min. The miconazole concentration in each 
sample and therefore solubility was determined 
from the measurement of miconazole and 
ketoconazole peak heights. 
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Figure 1: HPLC Chromatogram of miconazole (m) and 
ketoconazole (k). 
-
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Methods used in the microbiology 
experimentation: 
MIC and MFC determinations were carried out 
using a (macro) broth dilution technique, using a 
two-fold dilution series. 
The experiments designed to investigate the 
survival of Candida albicans challenged with 
miconazole in YNB and aqueous medium required 
the same materials needed for the MIC and MBC 
determinations, the procedure adopted was as 
follows: 
One loopful of C. albicans from a YMA slope was 
inoculated into buffered YNB (100 ml) and placed 
overnight in a shaking water bath (37°C, 
150 strokes/min).The experimental challenge was 
prepared by addition of 10 ml overnight culture 
into warmed buffered YNB and grown until an 
O.D.540 value of 0.5 was obtained. This culture (100 
ml) was collected on a 0.45 f.lm filter and rinsed with 
warmed media. The culture was then resuspended 
in 10 ml of warmed media. 
Sterile solutions of miconazole, 8 mg/L and 
16 mg/L in buffered YNB and 1% DMF, were 
prepared by hundred-fold dilution of the 
appropriate sterile stock solutions (in 100% DMF) 
with sterile buffered YNB. 
A volume (1 ml) of culture was used to 
inoculate the test media that consisted of 
miconazole in buffered YNB and 1% DMF. A 
control flask that did not contain miconazole 
was also inoculated with this culture The 
flasks were then incubated for a total of 24h 
during which samples were taken for viable 
count determinations. Throughout the 
exercise, the pour plate technique was used 
exclusively for viable count determinations. 
In this set of experiments replicate cultures exposed 
to concentrations of miconazole were used for each 
pH and concentration. 
Results 
The results of the theoretical solubilities of 
miconazole in buffer, obtained with the use of the 
Henderson-Hasselbalch equation10, and those 
determined by HPLC varied with changes of pH. 
Both sets of data show that the solubilities of 
miconazole at pH values above 6 are low (Table 1) 
and therefore media that contained more than 
3.99 mg/L miconazole in solution could not be 
prepared at pH 6 and above. Due to these results, 
the process of double membrane filtration, as a 
means of sterilisation, could not be directly and 
safely applied to aqueous growing media (with 1% 
vI v organic solvent) that contained more than 
3.99 mg/L miconazole. 
pH Mean solubility* Theoretical solubilityt 
(mg/L) (mg/L) 
5.0 28.90 129.84 
5.5 10.28 42.79 
6.0 3.99 15.27 
7.0 2.79 3.81 
8.0 2.37 2.67 
*(HPLC determination) 
t(Henderson-Hasselbalch equation calculation) 
Table 1: Mean solubility profile determined by HPLC 
and the theoretical pH solubility profile for 
miconazole estimated by the Henderson-
Hasselbalch equation as functions of pH. 
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Data from MIC and MFC determinations at pH 6 
and 7 showed that not more than a two-fold 
difference was obtained with determinations carried 
out at pH 6 and 7. Time survival experiments were 
performed with the MFC values obtained at these 
two pH values (Table 2). 
The data obtained from the time-survival experiments, 
carried out in YNB, was used to calculate the Area 
UndertheCurve(AUC)with theuseofthe Trapezoidal 
rule (Table 3). In YNB, at pH 6 and 7, at both 8 and 16 
mg/L, the algebraic sum of the AUC obtained is 
negative thus indicating that the deleterious effect 
exceeded that of growth. AtpH5 and 5.5 the algebraic 
sumoftheAUCispositive. It should be noted thatthe 
AUCs obtained for both 8 and 16 mg/L have been 
estimated to have the same area. 
The results obtained from experiments carried out in 
anaqueousmedium(Tables4),indicatearelationship 
between the extent of the killing process of the 
antifungal agent and pH of the medium. 
pH 
6.0 
7.0 
MIC 
(mg/L) 
4.00 
4.00 
MFC 
(mg/L) 
16.00 
8.00 
Table 2: MIC and MFC value for miconazole (mg/L) 
against C. albicans (NCPF 3262). 
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AUC Cone. Miconazole (Mean,± sd) 
pH 8mg!L 16mg/L 
5.0 + (11.90 ± 0.23) + (11.22 ± 0.61) 
5.5 + (3.36 ± 0.42) 
6.0 - (2.25 ± 8.85) - (43.92 ± 2.40) 
7.0 - (18.62 ± 16.47) - (32.61 ± 26.10) 
Table 3: The relationship between AUC, miconazole 
concentration and pH of growing medium for 
cultures of C. albicans growing in buffered YNB. 
AUC 
pH (Mean,±sd) 
5.0 + (17.53 ± 1.09) 
5.5 + (12.95 ± 0.91) 
6.0 - (11.18 ± 3.69) 
7.0 - (4.70 ± 1.86) 
8.0 - (3.22 ± 1.81) 
Table 4: TherelationshipbetweenAUCandpHofcultures 
of C. albicans growing in aqueous solutions of 
miconazole (8mg/L) containing 1% DMF. 
Discussion 
The sensitivity of C. albicans (NCPF 3262) to 
miconazole was assessed by MIC and MFC 
determinations. This isolate was sensitive to 
miconazole and the values were within the expected 
sensitivity range according to previous in-vitro 
determinations11. Results at pH 6 and 7 were 
similar with no result differing by more than one 
dilution. 
The inocula used throughout were obtained from 
cultures that were in log phase It has been suggested 
that the most effective killing occurs with organisms 
inmid-logphase. Less effective killing was reported 
withlatelogphaseorganismswiththeleasteffective 
killing occurring with organisms in the stationary 
phase; which factors could influence the outcome 
of tests12. 
Time-survival determinations. give a better 
understanding of the changes in viability that can 
occur over the test period and measurement of the 
AUC permits an overall view of the time-survival 
curve and has recently been used to examine the 
activity of antibiotics against Ps. aeruginosa 5. The 
results of the HPLC assay show thatthere is a direct 
relationship between pH and solubility of 
miconazole in a liquid medium. In other 
microbiological experimentation it has been shown 
that at pH 7, that there is a relationship between 
miconazole concentration and both rate of kill and 
AUC. A rapid increase in AUC was noted in the 
lower concentration range, but as concentration 
increased, the effect was considerably reduced13. 
13 
These effects may be due to the fact that at pH 7 the 
solubility of miconazole in an aqueous medium is 
low. The actual solubility ranges between 2.8 and 
3.8 mg/L, depending on whether the solubility is 
taken as that previously determined by HPLC or 
that determined by application of the Henderson-
Hasselbalch equation. Above pH 6, solubility of 
miconazoleinanaqueousmediumisthusaproblem 
when experimental procedures are designed to 
investigate the effect that specific concentrations of 
miconazole have on the behaviour of batch cultures 
of Candida albicans. Low solubility of miconazole in 
aqueous media, therefore did not permit the 
standard sterilisation by filtration of solutions, or 
rather suspensions, ofmiconazole in aqueous buffer 
solution or in aqueous buffered solutions of YNB. 
The two constituents had to be prepared separately 
and sterilised and then mixed together under aseptic 
conditions9. 
Apart from solubility, the deleterious effect exerted 
by miconazole may also be dependent on the degree 
of ionisation of the molecule. With a pKa of 6.7 
miconazole exists predominantly in its unionised 
form at pH 7 (apH 7 = 33.4%), which moiety is 
reported to be required for antimicrobial activity; 
in this case, direct lethal action that causes damage 
to C. albicans cells. This has led to the opinion that 
pH regulation of the direct lethal action of 
miconazole against C. albicans reflects the influence 
of the H+ ion on drug molecules, rather than on 
yeast cells. In fact non-protonated miconazole 
appears to be required for direct lethal action (D LA)6. 
-
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The effect of pH on solutions of miconazole (8 and 
16 mg/L in 1% DMF as solvent) in buffered 
aqueous solutions or in YNB (buffered to the 
required pH with Sorensen' s buffer) were markedly 
different. In YNB, the efficacy of miconazole 
increased with increasing pH, in which conditions 
solubility decreased and a the degree of ionisation 
decreased. In contrast, the efficacy of miconazole in 
aqueous solution, at lower pH was greater. 
In a growth medium such as YNB, components of 
the growth medium itself may exert some effect on 
the drug. As an example, the medium may adsorb 
the drug thus reducing the active concentration in 
solu:ion. A further factor associated with 
assessment of time-survival in growth medium 
compared to the aqueous solution, is the behaviour 
of the organism. The growth medium may protect 
the organism and aid its survival. 
The influence of media on the activity of azoles is 
well ;mown 11• However, it has not been previously 
demonstrated that this is complicated by the pH of 
the test conditions and this may account for some of 
the variability in the results reported. 
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